(Reuters) – Novavax Inc and its partner Serum Institute of India said on Thursday they had applied to the World Health Organization for an emergency use listing of Novavax’s COVID-19 vaccine.
(Reporting by Manas Mishra in Bengaluru; Editing by Maju Samuel)
